Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.
Emeline BrenardCharles PiletteCaroline DahlqvistBenoît ColinetFlorence SchleichFlorence RoufosseAntoine FroidurePublished in: Lung (2020)
In this open-label retrospective study, treatment of ICEP with mepolizumab was associated with a reduction of relapses, OCS use, and the disappearance of lung infiltrates.